Pulmonary & Sleep Consultants

Personal and Professional Pulmonary & Sleep services in South Florida

  • Home
  • Services
    • Pulmonary Medicine
    • Obstructive Sleep Apnea (OSA)
    • Lung nodules
  • Our Doctors
    • J.J. Rajter MD
    • Juliana Cepelowicz Rajter, MD
  • Contact Us
  • Resources
    • Instructions
    • Post a review
    • Hospital Affiliations
  • Blog
  • Patient Portal

Dietary and Exercise Recommendations for Patient Initiating GLP-1 Therapy

Patient counseled that pharmacologic therapy with a GLP-1 receptor agonist is intended to be used in conjunction with comprehensive lifestyle modification.

Nutrition Recommendations

  • Adopt a calorie-reduced, nutritionally balanced diet.
  • Emphasize lean proteins (fish, poultry, legumes), high-fiber vegetables, and low-glycemic carbohydrates.
  • Limit refined sugars, processed foods, saturated fats, and sugar-sweetened beverages.
  • Encourage small, frequent meals to minimize gastrointestinal side effects associated with GLP-1 therapy.
  • Maintain adequate hydration (≥64 oz water daily unless medically contraindicated).
  • Target daily protein intake of approximately 1.0–1.2 g/kg body weight to preserve lean muscle mass during weight loss.

Physical Activity Recommendations

  • Engage in ≥150 minutes per week of moderate-intensity aerobic activity (e.g., brisk walking, cycling).
  • Incorporate resistance training at least 2–3 times per week to maintain muscle mass.
  • Increase daily non-exercise activity (e.g., step count goal individualized to baseline).
  • Gradually advance activity level as tolerated.

Behavioral Strategies

  • Encourage food tracking and weight monitoring.
  • Promote adequate sleep (7–8 hours nightly).
  • Address stress management and behavioral triggers for overeating.

Patient verbalized understanding that sustained weight reduction and metabolic improvement require adherence to both medication and lifestyle modifications.

Recent Posts

  • Dr. Rajter’s opening statement to US Senate Homeland Security Hearing on early treatment for COVID-19.
  • Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)
  • Chest Journal. Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019
  • Chest Journal Club Webinar. Icon Study: Use of Ivermectin in Hospitalized Patients With COVID-19.

Contact Info

Pulmonary and Sleep Consultants
1001 S. Andrews Ave
Suite 100
Fort Lauderdale, FL 33316

Tel. 954-906-6000
Fax. 954-860-7650

Connect with us

  • Facebook
  • Twitter

Copyright © 2026 Pulmonary and Sleep Consultants     ·     Built by MySalesButler.com, LLC